


Postep®
erlotinib
Indications
- Non-small cell lung cancer.
- Pancreatic cancer.
Presentations
- 100 mg x 30 tablets
- 150 mg x 30 tablets
- 100 mg x 30 tablets
- 150 mg x 30 tablets